XML 133 R108.htm IDEA: XBRL DOCUMENT v3.20.4
Discontinued Operations (Narrative) (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 11, 2019
Sep. 24, 2018
Aug. 31, 2018
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Gain related to disposition         $ 0.0 $ 3,680.5 $ 0.0
Elanco              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Consideration received   $ 4,200.0          
Additional paid in capital   629.2          
Elanco | Discontinued Operations, Disposed of by Sale              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Gain related to disposition       $ 3,700.0      
Cash provided by operating activities, discontinued operations             $ 500.0
Transitional services agreement, term 24 months            
Elanco | Discontinued Operations, Disposed of by Sale | Eli Lilly and Company              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Disposition of ownership interest 80.20%            
Elanco              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Proceeds from issuance of debt   $ 2,000.0          
Elanco | Term Facility              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Debt instrument, face amount     $ 500.0        
Debt instrument, term     3 years        
IPO | Elanco              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Initial public offering (in shares)   72.3          
Percentage of stock sold   19.80%          
Sale of stock, price per share (in usd per share)   $ 24